Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3706923013 | Tildrakizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3706924019 | Tildrakizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1161601000172117 | tildrakizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1181241000172115 | tildrakizumab | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tildrakizumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Tildrakizumab (substance) | Is a | Substance with interleukin 23 receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some | ||
| Tildrakizumab (substance) | Has disposition (attribute) | Interleukin 23 receptor antagonist (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing tildrakizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Tildrakizumab (substance) | Inferred relationship | Some | 1 |
| Product containing tildrakizumab (medicinal product) | Has active ingredient | True | Tildrakizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only tildrakizumab (medicinal product) | Has active ingredient | True | Tildrakizumab (substance) | Inferred relationship | Some | 1 |
| Tildrakizumab only product in parenteral dose form | Has active ingredient | True | Tildrakizumab (substance) | Inferred relationship | Some | 1 |
| Tildrakizumab 100 mg/mL solution for injection | Has precise active ingredient | True | Tildrakizumab (substance) | Inferred relationship | Some | 1 |
| Tildrakizumab 100 mg/mL solution for injection | Has basis of strength substance (attribute) | True | Tildrakizumab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR